Paul Jabara’s glittering show business career was cut short tragically after he lost his life at just 43 due to AIDS. Now, the disease that took his life is no longer a death sentence thanks to strides made in the pharmaceutical industry. The advancement of AIDS treatment, in addition to other medications, would not be possible without the vital protections of intellectual property rights. On this episode of Stroke of Genius, host Raha Francis is joined by Henry Hadad, Senior Vice President and Deputy General Counsel at global biopharmaceutical company, Bristol-Myers Squibb, who discusses the importance of upholding intellectual property rights in drug development and clarifies misconceptions around the price of drugs. Henry also describes the impact of losing his uncle Paul Jabara and how this influenced his decision to pursue a career in drug development. 

To learn more about the life and work of Paul Jabara, you can visit this website created by his family. Henry Hadad has written and spoken extensively about the importance of the IP protection system to the drug development process. You can find some of his comments on Bloomberg Lawand Profile Magazine. He also moderated a special discussion about Patent Rights in the Pandemic in 2021 hosted by the IPO Education Foundation, which you can watch here.

Hosted on Acast. See acast.com/privacy for more information.